Intraday BUY SELL Signals
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$31.39
Change-$0.02 (-0.06%)
Volume$3.29K
Net Assets79.17M
GINX vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Dec 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a StrongBuy and GSK is a StrongBuy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | N/A |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 42% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 66% |
| MACD ODDS (%) | 1 day ago 67% | N/A |
| TrendWeek ODDS (%) | 1 day ago 89% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 58% |
| Advances ODDS (%) | 5 days ago 90% | 1 day ago 61% |
| Declines ODDS (%) | 10 days ago 61% | 9 days ago 51% |
| BollingerBands ODDS (%) | N/A | 1 day ago 41% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 53% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MARU | 28.07 | 0.07 | +0.27% |
| AllianzIM U.S. Equity Buffer15 UncMarETF | |||
| VMO | 9.56 | 0.01 | +0.10% |
| Invesco Municipal Opportunity Trust | |||
| SPSM | 48.01 | -0.01 | -0.02% |
| State Street SPDR Port S&P 600 Sm CpETF | |||
| KJUL | 31.88 | -0.03 | -0.09% |
| Innovator Russell 2000 Pwr Bffr ETF™ Jul | |||
| RNRG | 33.55 | -0.05 | -0.14% |
| Global X Renewable Energy Producers ETF | |||
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | -0.06% | ||
| GSK - GINX | 25% Poorly correlated | +0.25% | ||
| FMS - GINX | 23% Poorly correlated | +0.25% | ||
| SMFG - GINX | 23% Poorly correlated | -1.02% | ||
| SONY - GINX | 23% Poorly correlated | +0.47% | ||
| RELX - GINX | 23% Poorly correlated | +0.05% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y